{"id":"W4323532429","doi":"10.1182/bloodadvances.2022008414","title":"Dabrafenib, alone or in combination with trametinib, in <i>BRAF</i> V600–mutated pediatric Langerhans cell histiocytosis","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Hospital for Sick Children; National Cancer Institute; National Institute for Health and Care Research; National Institutes of Health; Novartis Pharmaceuticals Corporation","keywords":"Trametinib; Dabrafenib; Medicine; Combination therapy; MEK inhibitor; Internal medicine; Adverse effect; Vomiting; Tolerability; Oncology; Langerhans cell histiocytosis; Gastroenterology; Vemurafenib; MAPK/ERK pathway; Cancer; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001254343,0.000182372,0.0003607639,0.0004007765,0.00004307108,0.00001289262,0.00007137614,0.00006589581,0.00005991441],"category_scores_gemma":[0.0000753317,0.000135287,0.00003503489,0.001596239,0.00004204199,0.000143679,0.000014854,0.0001320207,0.00008309574],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006815134,"about_ca_system_score_gemma":0.0001275655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001604131,"about_ca_topic_score_gemma":0.0009986461,"domain_scores_codex":[0.9987318,0.00004103499,0.0003042501,0.0003338067,0.0002737058,0.0003154399],"domain_scores_gemma":[0.9994778,0.0001385237,0.00009466148,0.000167521,0.00003880964,0.00008267349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001631631,0.009716426,0.959762,0.0008271897,0.00009220903,0.00394594,0.002127628,0.0005858418,0.0005906615,0.00006296737,0.001154472,0.01950304],"study_design_scores_gemma":[0.195338,0.01013077,0.73085,0.001114751,0.002015646,0.0002464899,0.005095002,0.001553824,0.01774043,0.001130212,0.03279385,0.00199111],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936886,0.001320721,0.00001802357,0.000459013,0.00007559094,0.0005450746,0.0000229974,0.0001390192,0.003730936],"genre_scores_gemma":[0.9949257,0.001267797,0.0008061336,0.0001254056,0.00003426736,0.0001285505,0.0001852294,0.00003177064,0.002495173],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.228912,"threshold_uncertainty_score":0.5516843,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01175182767218733,"score_gpt":0.2581150176213485,"score_spread":0.2463631899491612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}